{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:49:34Z","timestamp":1783748974049,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jpsychires.2012.02.013","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T07:56:29Z","timestamp":1333007789000},"page":"757-761","source":"Crossref","is-referenced-by-count":32,"title":["The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients"],"prefix":"10.1016","volume":"46","author":[{"given":"Hikaru","family":"Hori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiji","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Katsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Ikenouchi-Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakako","family":"Umene-Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2012.02.013_bib1","series-title":"DSM-IV: diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.jpsychires.2012.02.013_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1192\/bjp.189.3.204","article-title":"Insight in psychosis and neuropsychological function: meta-analysis","volume":"189","author":"Alemen","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.02.013_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.2009.01455.x","article-title":"The prefrontal cortex: a target for antipsychotic drugs","volume":"121","author":"Artigas","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2012.02.013_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.psc.2005.05.004","article-title":"Cognition in schizophrenia: implications, and functional importance","volume":"28","author":"Bowie","year":"2005","journal-title":"Psychiatric Clinics North America"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.02.013_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00004714-200006000-00017","article-title":"Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia","volume":"20","author":"Bronson","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.jpsychires.2012.02.013_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4088\/JCP.08m04634","article-title":"Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison","volume":"70","author":"Crespo-Facorro","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2012.02.013_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1192\/bjp.bp.108.055137","article-title":"Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis","volume":"194","author":"Cuesta","year":"2009","journal-title":"The British Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.02.013_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/appi.ajp.2008.08060806","article-title":"Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)","volume":"166","author":"Davidson","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.02.013_bib9","series-title":"Structured clinical interview for DSM-IV axis I disorders, patient edition (SCID-P), version 2","author":"First","year":"1995"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.02.013_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1017\/S0033291708004558","article-title":"Working memory in schizophrenia: a meta-analysis","volume":"39","author":"Forbes","year":"2008","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.02.013_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10401230209147398","article-title":"Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria","volume":"14","author":"Gerlach","year":"2002","journal-title":"Annals of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.02.013_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hbm.20138","article-title":"Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia","volume":"25","author":"Glahn","year":"2005","journal-title":"Human Brain Mapping"},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2012.02.013_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.schres.2004.05.023","article-title":"The FOCIS international survey on psychiatrists\u2019 opinions on cognition in schizophrenia","volume":"74","author":"Green","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"10","key":"10.1016\/j.jpsychires.2012.02.013_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications: occupancy is not just antagonism","volume":"60","author":"Grunder","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.02.013_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00213-006-0654-2","article-title":"Unique pharmacological profile of aripiprazole as the phasic component buster","volume":"191","author":"Hamamura","year":"2007","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.02.013_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment","volume":"158","author":"Harvey","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.02.013_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","article-title":"Neurocognitive deficit in schizophrenia: a quantitative review of the evidence","volume":"12","author":"Heinrichs","year":"1998","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.02.013_bib18","first-page":"152","article-title":"Molecular brain imaging and the neurobiology and genetics of schizophrenia","volume":"36","author":"Heinz","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"5\u20136","key":"10.1016\/j.jpsychires.2012.02.013_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.eurpsy.2005.02.006","article-title":"Patient outcomes in schizophrenia II: the impact of cognition","volume":"20","author":"Hofer","year":"2005","journal-title":"European Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2012.02.013_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2006.05.004","article-title":"Antipsychotic medication and cognitive function in schizophrenia","volume":"86","author":"Hori","year":"2006","journal-title":"Schizophrenia Research"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.02.013_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1440-1819.2007.01725.x","article-title":"Brief assessment of cognition in schizophrenia: validation of the Japanese version","volume":"61","author":"Kaneda","year":"2007","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"9","key":"10.1016\/j.jpsychires.2012.02.013_bib22","first-page":"913","article-title":"The brief assessment of cognition in schizophrenia Japanese version (BACS-J)","volume":"50","author":"Kaneda","year":"2008","journal-title":"Seishinigaku"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.02.013_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pnpbp.2006.03.013","article-title":"High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction","volume":"30","author":"Kawai","year":"2006","journal-title":"Progress in Neuro-psychopharmacology and Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.02.013_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) manual","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"issue":"4","key":"10.1016\/j.jpsychires.2012.02.013_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neures.2009.12.007","article-title":"Investigation of clinical factors influencing cognitive function in Japanese schizophrenia","volume":"66","author":"Kishi","year":"2010","journal-title":"Neuroscience Research"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.02.013_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004850-200015020-00003","article-title":"Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia","volume":"15","author":"Krausz","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2012.02.013_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1037\/0021-843X.114.4.599","article-title":"Working memory impairments in schizophrenia: a meta-analysis","volume":"114","author":"Lee","year":"2005","journal-title":"Journal of Abnormal Psychology"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.02.013_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A\u00a0meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2012.02.013_bib29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11310820-000000000-00000","article-title":"Aripiprazole: dose\u2013response relationship in schizophrenia and schizoaffective disorder","volume":"23","author":"Mace","year":"2009","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.02.013_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/npp.2010.5","article-title":"Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum","volume":"35","author":"McClure","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.jpsychires.2012.02.013_bib31","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0893-133X(99)00046-9","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.jpsychires.2012.02.013_bib32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2004.01.027","article-title":"A\u00a0meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book","volume":"55","author":"Mishara","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.02.013_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004850-200201000-00007","article-title":"Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication","volume":"17","author":"Moritz","year":"2002","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.02.013_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.conb.2004.03.003","article-title":"The prefrontal cortex and working memory: physiology and brain imaging","volume":"14","author":"Passingham","year":"2004","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.jpsychires.2012.02.013_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophrenia Bulletin"},{"issue":"11","key":"10.1016\/j.jpsychires.2012.02.013_bib36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4088\/JCP.09r05060gre","article-title":"A\u00a0systematic review of aripiprazole\u2014dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring","volume":"71","author":"Sparshatt","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2012.02.013_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality","volume":"27","author":"Svensson","year":"2003","journal-title":"Progress in Neuro-psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.02.013_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-1781(91)90065-W","article-title":"Relationships between medication treatments and neuropsychological test performance in schizophrenia","volume":"37","author":"Sweeny","year":"1991","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.jpsychires.2012.02.013_bib39","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.neuroimage.2006.11.008","article-title":"Memory and frontal lobe functions: possible relations with dopamine D2 receptors in the hippocampus","volume":"34","author":"Takahashi","year":"2007","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.02.013_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0269881105057002","article-title":"The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review","volume":"20","author":"Thornton","year":"2006","journal-title":"Journal of Psychopharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612000684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612000684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T15:20:36Z","timestamp":1543072836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395612000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0022395612000684"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.02.013","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}